These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12513669)

  • 1. ECVAM: desperately needed or superfluous? An animal welfare perspective.
    Kolar R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():169-74. PubMed ID: 12513669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes.
    Louhimies S
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():217-9. PubMed ID: 12513679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The establishment of ECVAM and its progress since 1993.
    Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():5-11. PubMed ID: 12513646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. European Centre for the Validation of Alternative Methods.
    Worth AP; Balls M
    Altern Lab Anim; 2001; 29(5):525-35. PubMed ID: 11604096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new EU Chemicals Policy--comments of Eurogroup for Animal Welfare and the Deutscher Tierschutzbund on the EU-Commission's REACH system Consultation Documents.
    Sauer UG
    ALTEX; 2003; 20(3):225-7. PubMed ID: 12947488
    [No Abstract]   [Full Text] [Related]  

  • 6. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
    Stokes WS; Schechtman LM; Hill RN
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The principles of validation and the ECVAM validation process.
    Worth AP; Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance on determining indispensability and balancing potential benefits of animal experiments with costs to the animals with specific consideration of EU directive 2010/63/EU.
    Lindl T; Gross U; Ruhdel I; von Aulock S; Völkel M
    ALTEX; 2012; 29(2):219-28. PubMed ID: 22562491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC - a t4 report.
    Hartung T
    ALTEX; 2010; 27(4):285-303. PubMed ID: 21240470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialogue and collaboration: a personal view on laboratory animal welfare developments in general, and on ECVAM's first decade in particular.
    Koëter HB
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():207-10. PubMed ID: 12513676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.
    Pfuhler S; Kirkland D; Kasper P; Hayashi M; Vanparys P; Carmichael P; Dertinger S; Eastmond D; Elhajouji A; Krul C; Rothfuss A; Schoening G; Smith A; Speit G; Thomas C; van Benthem J; Corvi R
    Mutat Res; 2009; 680(1-2):31-42. PubMed ID: 19765670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement, Reduction, Refinement - Animal welfare progress in European Pharmacopoeia monographs: activities of the European Pharmacopoeia Commission from 2007 to 2017.
    Lang C; Kolaj-Robin O; Cirefice G; Taconet L; Pel E; Jouette S; Buda M; Milne C; Charton E
    Pharmeur Bio Sci Notes; 2018; 2018():12-36. PubMed ID: 29845933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The seventh amendment to the cosmetics directive: what does DG enterprise want from ECVAM?
    Schumann R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():213-4. PubMed ID: 12513678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRAME - reflections on the future and challenges to success.
    Flower C
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():53-5. PubMed ID: 20105013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on the sub-group reports of the EU Technical Expert Working Group on the revision of Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes.
    Combes R; Balls M
    Altern Lab Anim; 2007 Mar; 35(1):155-75. PubMed ID: 17411363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Revision of the EU Directive 86/609/EEC: results of the Internet consultations of the European Commission].
    Ruhdel I
    ALTEX; 2007; 24(1):41-5. PubMed ID: 17361320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reduction of animal experiments in experimental drug testing].
    Behrensdorf-Nicol H; Krämer B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1173-80. PubMed ID: 25183445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.